Recently, we described a new genetic disorder (the "hereditary hyperferritinemia-cataract syndrome") clinically characterized by the combination of elevated serum ferritin and congenital bilateral nuclear cataract, both cotransmitted as an autosomal dominant trait. In affected subjects, hyperferritinemia (ranging from 950 to 2,259 pg/L) is typically not related to iron overload. Differently from subjects with hereditary hemochromatosis, they have normal to low levels of serum iron and percent of transferrin saturation and absence of iron overload in parenchymal organs. When unnecessary phlebotomies are performed, they rapidly develop iron-deficient anemia, with persistently elevated levels of ERRITIN is an ubiquitous iron storage protein present in every cell of nearly all organisms. It is a multimer shell composed of 24 heavy (H, Mr 21,000) and light (L, Mr 19,000) subunits, surrounding a cavity that can accommodate up to 4,500 iron atoms in a readily available but nontoxic form.' The human genes for the H and L femtin subunits have been assigned to chromosome 1 1 and 19, respectively.' Iron availability finely regulates ferritin synthesis at the translational level by means of the so-called ironresponsive element binding protein (IRE-BP).3 In scarcity of iron, this cytosolic 90,000 Mr protein binds to an IRE situated on the S'-untranslated region (S' UTR) of the ferritin mRNA, thus inhibiting the initiation of the translation process. Alternatively, an excess of iron lowers the affinity of the IRE-BP for the IRE stem-loop in ferritin mRNA, enabling efficient translation (Fig 1) . In absence of conditions such as cancer and inflammation, which can also modulate femtin expression at transcriptional level by iron-independent, cytokine-mediated the above-mentioned mechanism is prominent, and represents perhaps the best understood example of posttranscriptional gene regulation in complex eukaryotes.? Ferritin is also present in the circulation, representing a by-product of intracellular ferritin synthesis.' Serum ferritin levels generally reflect the size of iron stores, providing a reliable marker for clinical evaluation of body iron status. Hereditary hemochromatosis, a parenchymal iron overload caused by excess iron absorption, has long been considered the only genetic disorder with elevated serum femtin.' Recently, we have described a new genetic disorder characterized by a combination of high serum ferritin not related to iron overload and congenital bilateral nuclear cataract, which is transmitted as an autosomal dominant trait.8 Since serum ferritin was determined in our patients using antibodies against the L-subunit, we suspected that the L-subunit gene on chromosome 19 (in the region 19q13.3 -19qter) might be involved. Moreover, the recent assignment to chromosome 19q13.4 of MP19, one of the most abundant proteins of lens fiber cell which is likely to be involved in cataractogenesis,' prompted us to actively search in this region of the human genome the gene responsible for the "hyperferritinemia-cataract syndrome." We searched for mutations on genomic DNA using the RNA-single-strand conformation polymorphism (RNA-SSCP) technique,"." focusing our attention first on ferritin L gene.
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In this report we describe a mutation in the 5' UTR of the gene for the ferritin L-subunit on chromosome 19q, which is likely to provide the molecular basis for the upregulation of ferritin synthesis in subjects affected by the "hyperferritinemia-cataract syndrome."
SUBJECTS AND METHODS

Subjects.
A detailed description of subjects affected by the "hyperfemtinemia-cataract syndrome" has been previously reported.R Briefly, they have congenital bilateral nuclear cataract and serum ferritin ranging from 950 to 2,259 pg/L. Differently from hereditary hemochromatosis patients, they have normal to low serum iron and transferrin saturation, and no evidence of parenchymal iron overload, as assessed by liver and bone marrow biopsy. When unnecessary phlebotomies are performed, they rapidly develop iron-deficient anemia (reversed by adequate iron therapy), with persistently elevated levels of serum ferritin. Further differences with respect to hereditary hemochromatosis are represented by the autosomal dominant transmission and the lack of relation with HLA. One of the two families previously described was immediately available for the genetic study. It was composed of 6 After electrophoresis, the pel was dried and suh.jected to autoradiography for I2 hours. Samples showing an electrophoretically altered mobility were then sequenced o n an automatic sequencer (Applied Biosystem 373A). according to manufacturer's protocols.
RESULTS
The S'UTR plus the four exons of ferritin L gene have been screened for the presence of nucleotide alterations. An electrophoretically abnormal band was detected in the affected members of the family analyzing the fragment corresponding to the S'UTR of the gene. Sequence analysis allowed us to identify a G -C substitution at nucleotide position 147 of the ferritin L gene sequence (EMBL sequence name HSAFL12) (Fig 2, top) . The mutation could be easily analyzed by PCR and agarose gel electrophoresis using a modified primer which introduces two base substitutions adjacent to the mutation site and create an artificial D& I restriction site," as shown on Fig 2 (bottom) .
DISCUSSION
The main feature of the recently described "hereditary hyperferritinemia-cataract syndrome" appears to be an excess of ferritin synthesis that is independent of the body iron stores. For example. if a mistaken diagnosis of hereditary hemochromatosis is made in affected subjects. they rapidly develop iron deficiency anemia in response to phlebotomies, whereas serum ferritin levels remain substantially elevated.x This prompted us to focus our attention first on ferritin L gene. RNA-SSCP technology is an accurate and sensitive method able to detect almost a l l kinds of nucleotide alterations present in a given DNA fragment."'." It allowed us to detect in affected subjects a nucleotide alteration in the S'UTR of the ferritin L gene. This mutation (named the -C substitution in the third residue of the 5-base sequence (CAGUG) that characterizes the loop structure of the IRE (Fig 3) . The IRES are stemloop structures of approximately 28 nucleotides, which are both necessary and sufficient for iron-mediated regulation of ferritin biosynthesis'j and highly conserved during the evolution; in particular, the CAGUG sequence of the loop is present in all the ferritin mRNAs examined in verteb r a t e~. '~ IRE-RP is the cytoplasmic protein that maintain cellular iron homeostasis by coordinating the translation of ferritin and transferrin receptor mRNAs. There is strong evidence that IRE-BP recognizes the IRE as a sequencdstructure motif,15 leading to inhibition of ferritin translation, except when iron is abundant. Extensive in vitro studies using synthetic IRE-analogue oligonucleotides have tested the effects of specific site-directed mutations either in the loop or in the upper stem.'.'' These mutational data suggested that the integrity of the CAGUG sequence in the loop as well as the base pairing along the upper stem are critical for the IRWIRE-BP high-affinity interaction. Also, a single-base deletion in the loop abolished the iron-mediated translational regulation in transfected cells.I3
More recently, 28 altered IRES with single-base mutations (substitution or deletion) in the loop or in the upper stem were tested for interaction with the IRE-BP, all resulting in a substantially decreased binding." It is noteworthy that this study included the evaluation of a synthetic IRE-RNA with a G -C single-base substitution in the third residue of the CAGUG loop sequence, which was identical to the spontaneous mutation detected by us. Competition experiments showed that this IRE-mutant interacted with the IRE-BP with a 28-fold lower affinity than did the native RNA.16 This bulk of in vitro observations strongly supports for the importance of the spontaneous G -C mutation we detected in subjects affected by the "hyperferritinemia-cataract syndrome." By altering the IRE/IRE-BP interaction, the Verona mutation is expected to determine the lack of attenuation of ferritin mRNA translation, leading ultimately to iron-insensitive, uncontrolled ferritin synthesis. In this way, the "hyperferritinemia-cataract syndrome" appears to be a unique human model providing insight into the in vivo regulation of iron homeostasis.
At present, we do not have a clear-cut explanation for the presence of bilateral cataract in subjects affected by the genetic disorder of the iron metabolism here described. Hereditary cataract is genotypically and phenotypically heterogeneous, and could be caused by either dysfunction of genes coding for lens-specific proteins or by alteration of the environment of the lens.I7 Recently, a membrane protein (MP19) of lens fiber cell has been assigned to chromosome 19ql3.4,' near the L-ferritin gene. However, it is difficult to see how a point mutation in the L-ferritin gene can lead to abnormal expression of the nearby MP19 gene. Similarly, it seems unlikely that the simultaneous presence of cataract and hyperferritinemia may be caused by a cosegregation of a mutated allele in each of the two genes lying in close vicinity. On the other hand, it is of interest to note that several lines of evidence argue in favour of a role of iron-related mechanisms in cataracts formation. First, iron-catalyzed reactions have been implicated in causing lens oxidative damage similar to that seen in cataractogenesis," and lens epithelial cells have been shown capable of active ferritin synthesis, especially in response to oxidative damage.I9 Second, ocular siderosis caused by retention of an iron-containing intraocular foreign body is frequently followed by cataract formation.'" Third, cataracts have been reported in patients with iron overload, especially when treated with the iron chelator deferroxamine.".*? Thus, it seems reasonable to speculate that the inappropriate production of ferritin may be directly responsible for cataract formation in individuals affected by this disorder of iron metabolism. Whether this hypothesis is true and the molecular mechanism(s) by which the disorder of ferritin synthesis may favor per se lens opacity remain to be determined. 
